A polymorphism in the estrogen receptor alpha gene ESR1 rs2234693, prostaglandin I2 synthase gene (rs493694) and another polymorphism in the interferon gamma gene rs2430561 is associated with a decreased risk of PDA and bronchopulmonary dysplasia (131, 132). This evidence concerns the gene ESR1 and Patent ductus arteriosus.